UC-San Diego: National Clinical Trial Launches, Will Test Promising Vaccine Against Novel Coronavirus
July 24, 2020
July 24, 2020
LA JOLLA, California, July 24 -- The University of California San Diego campus issued the following news:
UC San Diego Health and the Altman Clinical and Translational Research Institute, part of UC San Diego School of Medicine, will be sites for an accelerated national clinical trial to assess the efficacy and immunogenicity of a vaccine intended to protect against SARS-CoV-2, the novel coronavirus that causes COVID-19.
The trial, sponsored by the National Institutes o . . .
UC San Diego Health and the Altman Clinical and Translational Research Institute, part of UC San Diego School of Medicine, will be sites for an accelerated national clinical trial to assess the efficacy and immunogenicity of a vaccine intended to protect against SARS-CoV-2, the novel coronavirus that causes COVID-19.
The trial, sponsored by the National Institutes o . . .